RELATED CONTENT
NEWS
- 38 trial deaths in India in 2 years but SAE reporting overkill skewing data
- Foreign firms deny trials caused deaths in India amid concerns over reporting norms
- Pharma's negative image a real challenge, says Novartis India chief
- India underlines 'robust, balanced' IP regime at WIPO
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
- How do you hurt us? Let me count the ways: Assobiotec's Palmisano's lament
- A big job for a little biotech: SK Bio's growth plans

